|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 822.40 INR | +0.23% |
|
+0.61% | +2.91% |
| Capitalization | 45.42B 536M 507M 471M 420M 752M 833M 5.83B 2.16B 18.61B 2.01B 1.97B 80.5B | P/E ratio 2025 * |
30.3x | P/E ratio 2026 * | 24.2x |
|---|---|---|---|---|---|
| Enterprise value | 45.42B 536M 507M 471M 420M 752M 833M 5.83B 2.16B 18.61B 2.01B 1.97B 80.5B | EV / Sales 2025 * |
2.2x | EV / Sales 2026 * | 1.86x |
| Free-Float |
31.81% | Yield 2025 * |
0.3% | Yield 2026 * | 0.57% |
More valuation ratios
* Estimated data
More news
Last Transcript: Rossari Biotech Limited
| 1 day | +0.45% | ||
| 1 week | +0.83% | ||
| Current month | +0.83% | ||
| 1 month | +1.58% | ||
| 3 months | -6.54% | ||
| 6 months | +21.08% | ||
| Current year | +3.13% |
1 week
815.00
839.95
1 month
754.10854.00
Current year
656.95972.70
1 year
656.95972.70
3 years
536.351 382.00
5 years
536.351 619.00
10 years
536.351 619.00
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2019-09-30 | |
Ketan Sablok
DFI | Director of Finance/CFO | - | 2023-04-30 |
Manjiri Paranjpe
CTO | Chief Tech/Sci/R&D Officer | 48 | 2003-03-05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Menezes
CHM | Chairman | 64 | 2019-09-30 |
| Director/Board Member | 59 | 2009-08-09 | |
Aseem Dhru
BRD | Director/Board Member | 54 | 2019-11-11 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.35% | +0.83% | -0.83% | -36.41% | 536M | ||
| -0.35% | +0.11% | +30.52% | +12.29% | 70.22B | ||
| -0.43% | +1.97% | -2.43% | -35.24% | 42.48B | ||
| -0.09% | +1.19% | +18.89% | -14.07% | 41.08B | ||
| -0.35% | +0.65% | +17.09% | +18.66% | 27.35B | ||
| -0.67% | +0.48% | +0.72% | -28.00% | 16.76B | ||
| -0.19% | -0.96% | -1.48% | -16.84% | 15.28B | ||
| -1.47% | -6.37% | -10.74% | -59.80% | 11.88B | ||
| -0.08% | +2.07% | +17.36% | +48.99% | 11.4B | ||
| +1.04% | -1.43% | -22.41% | -33.98% | 10.86B | ||
| Average | -0.22% | -0.23% | +4.67% | -14.44% | 24.78B | |
| Weighted average by Cap. | -0.33% | +0.44% | +12.50% | -7.94% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.64B 244M 230M 214M 191M 342M 378M 2.65B 983M 8.45B 914M 895M 36.57B | 24.4B 288M 273M 253M 226M 404M 447M 3.13B 1.16B 10B 1.08B 1.06B 43.25B |
| Net income | 1.5B 17.66M 16.7M 15.52M 13.84M 24.77M 27.42M 192M 71.23M 613M 66.27M 64.85M 2.65B | 1.87B 22.08M 20.89M 19.41M 17.31M 30.98M 34.29M 240M 89.07M 766M 82.87M 81.1M 3.32B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
450
Sector
Specialty Chemicals
Calendar
2025-01-19
- Q3 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-06 | 822.40 ₹ | +0.23% | 25,134 |
| 24-12-05 | 820.50 ₹ | -0.22% | 19,162 |
| 24-12-04 | 822.35 ₹ | -1.20% | 36,518 |
| 24-12-03 | 832.35 ₹ | +1.16% | 28,729 |
| 24-12-02 | 822.80 ₹ | +0.65% | 35,015 |
Delayed Quote NSE India S.E., December 06, 2024 at 02:47 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
820.50INR
Average target price
988.25INR
Spread / Average Target
+20.44%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROSSARI Stock